Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-01-30

Clinical Trial Update: Safety and Efficacy Study of Topical Methyaminlevulinate (MAL) in Subjects With Facial Acne [Phase 2]

View source ↗

Summary

Phase 2 safety and efficacy results for topical methylaminolevulinate (MAL) in patients with facial acne.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Methylaminolevulinate (MAL) (methylaminolevulinate)

Snippet

Sponsor: Photocure | Conditions: Acne | Phase 2 | Status: COMPLETED